Trial Search Results
Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes
Diabetic pregnant patients are at risk for adverse pregnancy outcomes, including larger than expected fetuses and unplanned operative deliveries, due to elevated blood glucose levels. the one-hour glucola test is currently used to screen pregnant patients for gestational diabetes. This involves ingesting a 50-gram glucose load, followed by a blood test one hour later. We wish to compare 7-day continuous glucose monitoring to the one-hour glucola test, and determine which one correlates better with adverse pregnancy outcomes as well as which one more accurately identifies patients at risk for adverse pregnancy outcomes.
Stanford is currently not accepting patients for this trial.
Collaborator: DexCom, Inc.
- Device: The Seven Continuous Glucose Monitoring System
Phase 1/Phase 2
- Pregnant patients
- Age 18-50
- Gestational age less than 28 weeks
- Minors less than 18 years of age
- Multiple gestation
- Known fetal anomalies
Ages Eligible for Study
18 Years - 50 Years
Genders Eligible for Study